AbCellera Biologics Inc. Files 8-K
Ticker: ABCL · Form: 8-K · Filed: May 13, 2025 · CIK: 1703057
| Field | Detail |
|---|---|
| Company | Abcellera Biologics INC. (ABCL) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-reporting
TL;DR
AbCellera filed an 8-K on May 13th for events on May 12th.
AI Summary
AbCellera Biologics Inc. filed an 8-K on May 13, 2025, reporting other events and financial statements. The filing pertains to the period ending May 12, 2025. The company is incorporated in British Columbia and headquartered in Vancouver.
Why It Matters
This filing indicates routine corporate reporting and potential updates on financial statements or other significant events for AbCellera Biologics Inc.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for reporting events and financial statements, not indicating any immediate negative developments.
Key Players & Entities
- AbCellera Biologics Inc. (company) — Registrant
- May 12, 2025 (date) — Earliest event reported
- May 13, 2025 (date) — Date of report
- Vancouver, BC (location) — Principal executive office
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text does not detail the specific 'Other Events' being reported, only that this item is included in the filing.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This indicates that updated financial information or related exhibits are being provided to the SEC as part of this filing.
When was AbCellera Biologics Inc. incorporated?
AbCellera Biologics Inc. was incorporated in British Columbia, as stated in the filing.
What is the principal executive office address for AbCellera Biologics Inc.?
The principal executive office is located at 150 W 4th Avenue, Vancouver, BC V5Y 1G6.
What is the SEC file number for AbCellera Biologics Inc.?
The SEC file number for AbCellera Biologics Inc. is 001-39781.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding AbCellera Biologics Inc. (ABCL).